Anti-sleeping sickness drugs and cancer chemotherapy.
Barrett
S V
SV
Department of Medical Oncology, University of Glasgow, UK. m.barrett@bio.gla.ac.uk
Barrett
M P
MP
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000518:Eflornithine / Q000627:therapeutic use; D006801:Humans; D008549:Melarsoprol / Q000627:therapeutic use; D010419:Pentamidine / Q000627:therapeutic use; D013498:Suramin / Q000627:therapeutic use; D014344:Trypanocidal Agents / Q000627:therapeutic use*; D014346:Trypanosoma brucei brucei / Q000187:drug effects*; D014353:Trypanosomiasis, African / Q000188:drug therapy*
D000970:Antineoplastic Agents; D014344:Trypanocidal Agents; D013498:Suramin; D010419:Pentamidine; D008549:Melarsoprol; D000518:Eflornithine